Microfluidics technology for physiologically relevant assays
Jeff Jensen, CEO of Fluxion Biosciences describes how microfluidics technology fuels drug discovery through physiologically relevant cell-based models
Source: selectscience.net
Stay updated with breaking news from Catarina Rap. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jeff Jensen, CEO of Fluxion Biosciences describes how microfluidics technology fuels drug discovery through physiologically relevant cell-based models
Jeff Jensen, CEO of Fluxion Biosciences describes how microfluidics technology fuels drug discovery through physiologically relevant cell-based models